United States · FDA National Drug Code directory

Cefdinir

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 68788-7844_4a9cc651-518c-411a-956e-77213d2d1336
Product NDC: 68788-7844
Form: POWDER, FOR SUSPENSION
Composition / generic term: Cefdinir
Labeler: Preferred Pharmaceuticals Inc.
Marketing category: ANDA
Marketing start / end (source format): 20210120
Source listing expiry: 20271231

Source-listed ingredients

CEFDINIR — 250 mg/5mL

These values do not establish equivalence or a dose recommendation.

Packages

Package details are not available in this snapshot.

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →